Ali Chakera

2.3k total citations
40 papers, 1.2k citations indexed

About

Ali Chakera is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Ali Chakera has authored 40 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Surgery and 10 papers in Genetics. Recurrent topics in Ali Chakera's work include Pancreatic function and diabetes (13 papers), Diabetes Management and Research (12 papers) and Gestational Diabetes Research and Management (7 papers). Ali Chakera is often cited by papers focused on Pancreatic function and diabetes (13 papers), Diabetes Management and Research (12 papers) and Gestational Diabetes Research and Management (7 papers). Ali Chakera collaborates with scholars based in United Kingdom, United States and Uganda. Ali Chakera's co-authors include Andrew T. Hattersley, Sian Ellard, Bijay Vaidya, Beverley M. Shields, Maggie Shepherd, Simon H. S. Pearce, Anna Steele, Anna L. Gloyn, Gill Spyer and Kevin Colclough and has published in prestigious journals such as Diabetes Care, Clinical Infectious Diseases and The American Journal of Medicine.

In The Last Decade

Ali Chakera

34 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ali Chakera United Kingdom 15 606 423 423 393 155 40 1.2k
Chunlin Wang China 16 105 0.2× 126 0.3× 104 0.2× 205 0.5× 204 1.3× 62 845
Antti Kupila Finland 14 857 1.4× 869 2.1× 1.2k 2.8× 65 0.2× 120 0.8× 19 1.5k
Xin Long China 13 301 0.5× 69 0.2× 121 0.3× 152 0.4× 134 0.9× 48 972
Ryuichi Sakamoto Japan 20 311 0.5× 376 0.9× 56 0.1× 185 0.5× 261 1.7× 78 1.0k
Paula Vieira Teixeira Vidigal Brazil 17 151 0.2× 115 0.3× 45 0.1× 139 0.4× 300 1.9× 66 785
Soraya Allas United States 13 114 0.2× 121 0.3× 159 0.4× 120 0.3× 64 0.4× 26 601
Rosanna Lampis Italy 11 299 0.5× 192 0.5× 427 1.0× 202 0.5× 183 1.2× 13 881
Didier Chevenne France 12 82 0.1× 146 0.3× 130 0.3× 193 0.5× 83 0.5× 30 598
P Drouin Canada 13 137 0.2× 80 0.2× 51 0.1× 94 0.2× 93 0.6× 64 568
Datis Kharrazian United States 11 147 0.2× 109 0.3× 79 0.2× 140 0.4× 69 0.4× 23 919

Countries citing papers authored by Ali Chakera

Since Specialization
Citations

This map shows the geographic impact of Ali Chakera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Chakera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Chakera more than expected).

Fields of papers citing papers by Ali Chakera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Chakera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Chakera. The network helps show where Ali Chakera may publish in the future.

Co-authorship network of co-authors of Ali Chakera

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Chakera. A scholar is included among the top collaborators of Ali Chakera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Chakera. Ali Chakera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hope, S, et al.. (2024). Type 1 diabetes and frailty: A scoping review. Diabetic Medicine. 41(8). e15344–e15344. 2 indexed citations
2.
Hughes, Alice E., Jayne Houghton, Ali Chakera, et al.. (2023). Bringing precision medicine to the management of pregnancy in women with glucokinase-MODY: a study of diagnostic accuracy and feasibility of non-invasive prenatal testing. Diabetologia. 66(11). 1997–2006. 4 indexed citations
3.
Hope, S, et al.. (2023). The evolving continuum of dysglycaemia: Non‐diabetic hyperglycaemia in older adults. Diabetic Medicine. 40(10). e15177–e15177.
4.
Chakera, Ali, et al.. (2023). Lithium Monotherapy in Graves Thyrotoxicosis. JCEM Case Reports. 1(4). luad094–luad094.
5.
Levett, Tom, et al.. (2023). HIV and type 2 diabetes: An evolving story. HIV Medicine. 25(4). 409–423. 4 indexed citations
6.
7.
Wright, Juliet, et al.. (2020). The investigation of diabetes in people living with HIV: A systematic review. Diabetic Medicine. 38(4). e14454–e14454. 8 indexed citations
9.
Bowman, Pamela, Jacob Day, Lorna Torrens, et al.. (2018). Cognitive, Neurological, and Behavioral Features in Adults With KCNJ11 Neonatal Diabetes. Diabetes Care. 42(2). 215–224. 21 indexed citations
10.
Chakera, Ali, Gill Spyer, W. Marsh, et al.. (2018). Molecular reductions in glucokinase activity increase counter-regulatory responses to hypoglycemia in mice and humans with diabetes. Molecular Metabolism. 17. 17–27. 37 indexed citations
11.
Chakera, Ali, Timothy J. McDonald, Bridget Knight, Bijay Vaidya, & Angus G. Jones. (2017). Current laboratory requirements for adrenocorticotropic hormone and renin/aldosterone sample handling are unnecessarily restrictive. Clinical Medicine. 17(1). 18–21. 14 indexed citations
12.
Vedovato, Natascia, Kashyap Patel, Nicholas J. Thomas, et al.. (2016). Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes. Diabetologia. 59(6). 1162–1166. 61 indexed citations
13.
Grant, Paul, et al.. (2014). When to suspect ‘funny’ diabetes. Clinical Medicine. 14(6). 663–666. 1 indexed citations
15.
Igoillo‐Esteve, Mariana, Nelle Lambert, Julie Désir, et al.. (2013). tRNA Methyltransferase Homolog Gene TRMT10A Mutation in Young Onset Diabetes and Primary Microcephaly in Humans. PLoS Genetics. 9(10). e1003888–e1003888. 95 indexed citations
16.
Stride, Amanda, Beverley M. Shields, Ali Chakera, et al.. (2013). Cross-sectional and longitudinal studies suggest pharmacological treatment used in patients with glucokinase mutations does not alter glycaemia. Diabetologia. 57(1). 54–56. 139 indexed citations
17.
Chakera, Ali & Bijay Vaidya. (2010). Addison Disease in Adults: Diagnosis and Management. The American Journal of Medicine. 123(5). 409–413. 33 indexed citations
18.
Taseera, Kabanda, Ali Chakera, Irene Andia, et al.. (2010). Regional Anthropometry Changes in Antiretroviral-Naïve Persons Initiating a Zidovudine-Containing Regimen in Mbarara, Uganda. AIDS Research and Human Retroviruses. 27(7). 785–791. 11 indexed citations
19.
Longley, Nicky, Conrad Muzoora, Kabanda Taseera, et al.. (2008). Dose Response Effect of High‐Dose Fluconazole for HIV‐Associated Cryptococcal Meningitis in Southwestern Uganda. Clinical Infectious Diseases. 47(12). 1556–1561. 143 indexed citations
20.
Caplen, Natasha J., Xiang Gao, Peter Hayes, et al.. (1994). Gene therapy for cystic fibrosis in humans by liposome-mediated DNA transfer: the production of resources and the regulatory process.. PubMed. 1(2). 139–47. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026